Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
10/2003
10/02/2003US20030187007 Inhibitors of protein kinase for the treatment of disease
10/02/2003US20030187004 Central nervous system disorders; Alzheimer's disease
10/02/2003US20030186999 Purine derivatives having, in particular, antiproliferative properties, and their biological uses
10/02/2003US20030186996 Angiogenesis inhibitors
10/02/2003US20030186989 Antihistamines; respiratory system disorders
10/02/2003US20030186987 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
10/02/2003US20030186981 Antiinflammatory agents; osteoporosis; rheumatic diseases; autoimmune diseases
10/02/2003US20030186974 Pyrrolyl- and imidazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes
10/02/2003US20030186970 Androgen receptor modulator compounds and methods
10/02/2003US20030186966 Antiinflammatory agents; autoimmune disease; antiallergens
10/02/2003US20030186958 Viricides, vision defects, oral diseases, antiarthritic agents, multiple sclerosis, anticancer agents
10/02/2003US20030186957 Methods of treatment and formulations of cephalosporin
10/02/2003US20030186951 Compositions and methods for enhancing corticosteroid delivery
10/02/2003US20030186945 Method of preparing and use of prodrugs of betulinic acid derivatives
10/02/2003US20030186941 Cyclopenteneone derivatives
10/02/2003US20030186934 For use as skin-whitening agents; side effects reduction
10/02/2003US20030186922 Therapeutic use of cis-element decoys in vivo
10/02/2003US20030186902 Use of a pituitary tumor transforming gene peptide which has the ability to regulate endogenous PTTG1 expression and/or function in a dominant negative manner
10/02/2003US20030186891 Polypeptide comprising fragments of matrix extracellular phosphoglycoproteins used to control calcitriol concentrations in cells, for prophylaxis of bone disorders
10/02/2003US20030186889 Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using a specific chemokine receptor analysis and the chemokine receptor-ligand interaction
10/02/2003US20030186875 Uses of mammalian cytokine; related reagents
10/02/2003US20030186857 Use of 3-position cyclosporin derivatives for hair growth
10/02/2003US20030186842 Contacting a cell population with an inhibiting effective amount of a reagent that suppresses the protease activity of at least one member of the interleukin-1beta- converting enzyme (ICE)/CED-3 family
10/02/2003US20030186337 Novel death associated proteins, and THAP1 and PAR4 pathways in apoptosis control
10/02/2003US20030186308 Prostacyclin-stimulating factor-2
10/02/2003US20030185864 Preventives or remedies for atopic dermatitis
10/02/2003US20030185824 Administering an inhibitor of the CD2/LFA-3 interaction, in combination with an auxiliary agent, such as UV-B
10/02/2003US20030185816 Modified immunogenic self-protein and a surfactant capable of acting as a solubiliser, especially modified human TNF alpha and cetylpyridinium chloride
10/02/2003US20030185815 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
10/02/2003US20030185794 Such as a pleiotrophin or midkine molecule in a pharmaceutically acceptable carrier.
10/02/2003US20030185786 Bis(polyoxyalkylene) fumarate; epidermal permeability barrier function enhancer, amphiregulin expression inhibitor, epidermal hyperproli- feration inhibitor, HB-EGF expression inducing agent, ameliorating agent for aged skin
10/02/2003US20030185784 N-lauroyl- or N-cocoyl- amino acid and potassium dimethicone copolyol panthenyl phosphate; protecting hair from damage
10/02/2003US20030185778 Polyamine compounds and compositions for use in conjunction with cancer therapy
10/02/2003US20030185772 Alleviates skin irritation by blending in polypropylene glycol, a specific polar oil, or polybutylene glycol, as well as an ultraviolet absorbent.
10/02/2003CA2761440A1 Fredericamycin derivatives
10/02/2003CA2756798A1 (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
10/02/2003CA2480385A1 Alkoxypyridine derivatives as nitric oxide synthase inhibitors
10/02/2003CA2480384A1 Phenanthridinones as parp inhibitors
10/02/2003CA2480302A1 Compositions and methods for treating and preventing necrosis
10/02/2003CA2480039A1 Spiro derivatives and adhesion molecule inhibitors comprising the same as active ingredient
10/02/2003CA2480007A1 Topical composition based on ion-exchange resins, in particular for treating erythemas
10/02/2003CA2479881A1 Hif hydroxylase inhibitors
10/02/2003CA2479880A1 Combination comprising an hmg-coa reductase inhibittor and an insulin secretor enhancer or an insulin sensitizer
10/02/2003CA2479722A1 Combination of an aldosterone receptor antagonist and a fibric acid derivative
10/02/2003CA2479671A1 Combination of an aldosterone receptor antagonist and nicotinic acid for a nicotinic acid derivative
10/02/2003CA2479259A1 Combination of an aldosterone receptor antagonist and a bile acid sequestering agent
10/02/2003CA2479123A1 Dihydronepetalactone as insect repellent
10/02/2003CA2478913A1 Substituted chroman derivatives having cytochrome p450rai inhibitory activity
10/02/2003CA2478839A1 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof
10/02/2003CA2477651A1 Kinase inhibitors
10/01/2003EP1348709A2 Thiazolo (4,5-D) pyrimidine compounds
10/01/2003EP1348707A1 Pyrazolo[4,3-d]pyrimidines, processes for their preparation and methods for therapy
10/01/2003EP1348706A1 Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof
10/01/2003EP1348434A1 Use of pyridyl amides as inhibitors of angiogenesis
10/01/2003EP1348421A2 A method of thickening and styling human keratinous fibres using a particular catalytic system
10/01/2003EP1348022A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/01/2003EP1347990A2 Peptide mit inhibierender aktivität zur produktion von stickstoffmonoxid
10/01/2003EP1347976A2 Tricyclic purine compounds and their analogs as inhibiotrs of cytokine signalling
10/01/2003EP1347972A1 Pyrazolo 3,4-c]pyridines as gsk-3 inhibitors
10/01/2003EP1347971A1 Thiazolyl inhibitors of tec family tyrosine kinases
10/01/2003EP1347968A1 Lfa-1 antagonist compounds
10/01/2003EP1347966A1 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives
10/01/2003EP1347959A1 Indole derivatives as ligands of thyroid receptors
10/01/2003EP1347805A2 Pharmaceutical preparation for douches and/or irrigations of natural or pathological cavities in the human body
10/01/2003EP1347768A1 Cosmetic and/or dermopharmaceutical preparations containing leaf extracts of the plant argania spinosa
10/01/2003EP1347765A2 Dermatological formulations
10/01/2003EP1347755A2 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
10/01/2003EP1347752A2 Anti-proliferative drugs
10/01/2003EP1347749A2 Transdermal therapeutic system comprising the active ingredient oxybutynin
10/01/2003EP1202954B1 Novel aminobenzophenones
10/01/2003EP1200435B1 Purine derivatives inhibitors of tyrosine protein kinase syk
10/01/2003EP1097712B1 Steroid-containing cataplasms and process for producing the same
10/01/2003EP1014998B1 Polymeric compositions
10/01/2003EP0998473B1 Crystal modification of a n-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
10/01/2003EP0758882B1 Use of n-acetyl-l-cysteine for lightening hyperpigmented skin
10/01/2003CN1446261A Modified cytokines for use in cancer therapy
10/01/2003CN1446227A Novel fibroblast growth factor (FRF23) and method for use
10/01/2003CN1446218A Benzimidazole derivatives, preparation method and therapeutic use thereof
10/01/2003CN1446214A Cinnoline compounds
10/01/2003CN1446212A Quinoline derivatives having VEGF inhibiting activity
10/01/2003CN1446197A Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
10/01/2003CN1446193A Aminoadamantane derivatives as therapeutic agents
10/01/2003CN1446108A Pharmaceutical form comprising a support material and at least a cell regulating factor and/or cell proliferation promoter
10/01/2003CN1446098A Modulation of alpha-6 integrin-mediated responses
10/01/2003CN1445236A Oligopeptides for promoting hair growing
10/01/2003CN1444985A Oil for comforting channels and collaterals
10/01/2003CN1444984A Oil from trees
10/01/2003CN1444977A Medicine combination containing valid part of ÔÇÿRuyi Jinhuang SanÔÇÖ and its preparing method
10/01/2003CN1444976A Preparation of Chinese herbal medicine for treating cold injury, various indurations and swelling, pain as well as its preparing method
10/01/2003CN1444974A Capsule with high cellulose for expelling of toxin and nourishing skin as well as its manufacturing methods
10/01/2003CN1444967A Chinese herbal medicine preparation for treating burns
10/01/2003CN1444958A External used ointment for skin
10/01/2003CN1444956A Cleansing pox remover
10/01/2003CN1123050C Method of improving skin condition
10/01/2003CN1122662C Arylsulfonylamino hydroxamic acid derivatives
10/01/2003CN1122521C Coptis liquid for relieving inflammation and moistening skin and its preparing process
10/01/2003CN1122513C Use of compound in medicine for preparation of inhibiting pathological conditions
10/01/2003CN1122443C Antiparasitic composition for treating and protecting pets
09/2003
09/30/2003US6627754 Pyrrolo[2,3-d]pyrimidine compounds
09/30/2003US6627731 Thrombin derived polypeptides; compositions and methods for use
1 ... 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 ... 1065